ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate

NCT02106507 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: apalutamide
DRUG: Everolimus

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]